<SEC-DOCUMENT>0001104659-25-044423.txt : 20250605
<SEC-HEADER>0001104659-25-044423.hdr.sgml : 20250605
<ACCEPTANCE-DATETIME>20250505115949
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-25-044423
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theriva Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Synthetic Biologics, Inc.
		DATE OF NAME CHANGE:	20120305

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="Theriva Biologics Inc.: Theriva ..." STYLE="height: 126px; width: 238px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 221.4pt; text-indent: 30.6pt">May 5, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 221.4pt; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>VIA EDGAR</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States Securities and Exchange Commission<BR>
Division of Corporation Finance<BR>
100 F Street, N.E.<BR>
Washington, D.C. 20549<BR>
Attention: Tamika Sheppard</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">Re:</TD><TD>Theriva Biologics, Inc.<BR>
Registration Statement on Form S-1<BR>
Filed December&nbsp;10, 2024, as amended<BR>
File No: 333-283722</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Ms. Sheppard:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Theriva Biologics, Inc. (the
 &ldquo;<B>Registrant</B>&rdquo;) hereby requests that the effective date of the above-referenced Registration Statement on Form S-1 (File
No. 333-283722), as amended, be accelerated by the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) to become
effective on <B>Wednesday, May 7, 2025</B>, at <B>9:00 a.m</B>., Eastern Time, or as soon as reasonably practicable thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Registrant understands
that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities
under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Registrant hereby authorizes
Leslie Marlow of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 457-4238
with any questions you may have concerning this request, and please notify her when this request for acceleration has been granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">THERIVA BIOLOGICS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 6%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%">/s/ Steven A. Shallcross</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Steven A. Shallcross</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">cc: Leslie Marlow, Blank Rome LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" "= 2H# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***3I0 M)1FLO7/$.G^'[0S7TZH2/DC'+N?0"FD
MY.RW!NQJ45P.B_%*SOM0:#48/L43M^YE+;ACT;T/Z5W:NLB*Z,K*W(93D$54
MZ<H.TD)-/8?F@'FN9\1^,K71&:"%1<7@ZQ@X"?4U=\/^)K+7H086\N<#YX7/
MS#Z>HH]G-1YFA<ZO8VJ*3(HR*@H6BDHS0 M%)D49H 6BDS2T %%%% !1110
M4444 %%%)D4 +129%+0 4444 %%%% !1110 4444 %%%% !1110 4AZ4M% '
M >*_B3#IKR66CJL]VI*O*P^2,_U-><Q0ZKXHU4[!->W<GWFSG:/KT I\]LEW
MXNEMGR$FOFC8KU +\UZO>BV\'V,5II-JD7F Y<\GCN3W/->G%*DE&"O)G+4F
ME%RGLC@M8^&NJZ9IJ743)=L%S/%$,%/I_>%5?#'C;4/#;B%MUQ8YPT#GE?\
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MS&&UM_ORXS@GLHZ9KI-<^%:V6F2W.FWLLLL2EVBE4?.!Z$=#6W\*HE3PK(X
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M,UB_"72-L5WJCKRQ\B+/8#EOZ5%']U3E4>^R')\TDC1\:^!Y_$>K65S9R)&
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M*KXV?DC:)>GF]\?3UKT%&<6Y4G=2/-IXF,8J%9--(2RT+2?"T:SWQ%YJ Y"
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G HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
